Myriad Genetics Statistics
NASDAQ: MYGNHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
4.20-0.08 (-1.87%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
After hours: 4.20 0.00%
Myriad Genetics by the numbers
Myriad Genetics has a market capitalization of $401.7 million based on 95.65M shares outstanding. With trailing EPS of $-1.18, Myriad Genetics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 16.8% above its 50-day average and 10.9% below its 200-day average.
Average daily trading volume is 2.02M shares, or about $8.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
MYGN valuation vs. peer median
| Metric | MYGN | Peer median | Difference |
|---|---|---|---|
| Market cap | $401.73M | $97.94M | +310% |
| Avg. volume | 2.02M | 189.10K | +966% |
Peer median across 8 companies: TKNO, NNNN, IMDX, ICCC, ACHV, BMRA, VNRX, CDIO.
Valuation
- Market cap
- $401.73M
- EPS (TTM)
- $-1.18
- Shares outstanding
- 95.65M
Price and trading
- Previous close
- 4.28
- Open
- 4.24
- Day range
- 4.05 – 4.26
- 52-week range
- 2.74 – 8.59
- 52-week change
- -43.16%
- Beta
- —
- Volume
- 2.26M
- Average volume
- 2.02M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 2, 2026
Additional statistics
- Market Cap
- 401.73M
- Forward Pe
- -7.12
- Eps
- -1.18
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 8.59
- Week52 Low
- 2.74
- Avg Volume
- 2.02M
- Shares Outstanding
- 95.65M
- Ma50
- 3.60
- Ma200
- 4.71
- Earnings Date
- Nov 2, 2026
- Pct From52w High
- -51.11%
- Pct From52w Low
- 53.28%